These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1164818)

  • 1. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1975 Sep; 18(3):287-97. PubMed ID: 1164818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged delta-9-tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockades.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1977 Mar; 21(3):336-42. PubMed ID: 837652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade.
    Kanakis C; Pouget JM; Rosen KM
    Circulation; 1976 Apr; 53(4):703-7. PubMed ID: 1253395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of delta-9-tetrahydrocannabinol in man.
    Weiss JL; Watanabe AM; Lemberger L; Tamarkin NR; Cardon PV
    Clin Pharmacol Ther; 1972; 13(5):671-84. PubMed ID: 4559810
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular system effects of marijuana.
    Jones RT
    J Clin Pharmacol; 2002 Nov; 42(S1):58S-63S. PubMed ID: 12412837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral delta-9-tetrahydrocannabinol administration in man.
    Benowitz NL; Jones RT; Lerner CB
    J Clin Endocrinol Metab; 1976 May; 42(5):938-41. PubMed ID: 1270583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethylheptyl-delta 6a-10a-tetrahydrocannabinol: effects after parenteral administration to man.
    Sidell FB; Pless JE; Neitlich H; Sussman P; Copelan HW; Sim VM
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):867-73. PubMed ID: 4571010
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms.
    Benowitz NL; Rosenberg J; Rogers W; Bachman J; Jones RT
    Clin Pharmacol Ther; 1979 Apr; 25(4):440-6. PubMed ID: 428189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
    Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
    Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.
    Pabon E; Rockwood F; Norman GJ; de Wit H
    Psychophysiology; 2022 Feb; 59(2):e13955. PubMed ID: 34665890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of nabilone, a cannabinol derivative.
    Lemberger L; Rowe H
    Clin Pharmacol Ther; 1975 Dec; 18(6):720-6. PubMed ID: 1204278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of delta9-tetrahydrocannabinol with oxymorphone or pentobarbital: Effects on ventilatory control and cardiovascular dynamics.
    Johnstone RE; Lief PL; Kulp RA; Smith TC
    Anesthesiology; 1975 Jun; 42(6):674-84. PubMed ID: 48348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of cardiovascular effects of delta-9-tetrahydrocannabinol in chemically denervated men.
    Kanakis C; Pouget M; Rosen KM
    Ann Intern Med; 1979 Oct; 91(4):571-4. PubMed ID: 484957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man.
    Benowitz NL; Jones RT
    J Clin Pharmacol; 1981; 21(S1):214S-223S. PubMed ID: 6271827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of cannabinol during oral surgery.
    Gregg JM; Campbell RL; Levin KJ; Ghia J; Elliott RA
    Anesth Analg; 1976; 55(2):203-13. PubMed ID: 769605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanol.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1977 Sep; 22(3):259-68. PubMed ID: 891094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic administration of delta 9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in freely moving rats.
    Kawasaki H; Watanabe S; Ueki S
    Eur J Pharmacol; 1980 Jul; 65(1):63-9. PubMed ID: 6249621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of delta-9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in rats.
    Kawasaki H; Watanabe S; Oishi R; Ueki S
    Jpn J Pharmacol; 1980 Aug; 30(4):493-502. PubMed ID: 6259394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.